• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charming Medical Limited - Class A Ordinary Shares (NQ:MCTA)

29.36 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charming Medical Limited - Class A Ordinary Shares

< Previous 1 2 Next >
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
February 17, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
February 16, 2026
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before the February 17th Class Action Lead Plaintiff Deadline
February 15, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Deadline Approaching: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
February 12, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Deadline Soon: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
February 12, 2026
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Deadline Alert: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
February 12, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
February 12, 2026
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before the February 17th Class Action Lead Plaintiff Deadline
February 11, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
February 09, 2026
From Schall Law
Via GlobeNewswire
News headline image
CHARMING MEDICAL CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before February 17th
February 06, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
February 05, 2026
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Urges Charming Medical Limited Stockholders With Large Losses to Contact the Firm Before the February 17th Lead Plaintiff Deadline
February 03, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
February 03, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Shareholder Rights Law Firm Robbins LLP Urges MCTA Investors to Contact the Firm About Their Rights Against Charming Medical, Limited
February 02, 2026
From Robbins LLP
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
February 02, 2026
From Schall Law
Via GlobeNewswire
News headline image
CHARMING MEDICAL LAWSUIT REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds Charming Medical Limited Stockholders to Contact the Firm Before the February 17th Class Action Lead Plaintiff Deadline
January 30, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MCTA CLASS ACTION ALERT: Robbins LLP Urges Charming Medical, Limited Stockholders with Large Losses to Contact the Firm About Leading the Class Action
January 29, 2026
From Robbins LLP
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
January 29, 2026
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
January 27, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
January 26, 2026
From Schall Law
Via GlobeNewswire
News headline image
CHARMING MEDICAL LAWSUIT REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds Charming Medical Limited Stockholders to Contact the Firm Before the February 17th Class Action Lead Plaintiff Deadline
January 24, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CHARMING MEDICAL CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges Charming Medical Limited Stockholders to Contact the Firm Before the February 17th Lead Plaintiff Deadline
January 20, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
January 20, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
January 20, 2026
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
January 13, 2026
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
January 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
January 06, 2026
From Schall Law
Via GlobeNewswire
News headline image
CHARMING ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Charming Medical Limited and Encourages Investors to Contact the Firm
January 05, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Charming Medical Limited (NASDAQ: MCTA)
January 05, 2026
From Scott+Scott Attorneys at Law LLP
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap